Wednesday 20 March 2019

A new #phase I/II open-label, a dose-escalation trial has recently tested the effectiveness of a "Trojan horse" #drug in treating multiple types of otherwise ##treatment-resistant #cancer in its late stages. 
#trojanhorse  #clinicaltrials  #Oncology #Pharmacology #clinicalresearch #Clinicaltrials2019

No comments:

Post a Comment